​

Carmell Therapeutics (CTCX) Revenue & Revenue Breakdown

OverviewFinancialsChart

Carmell Therapeutics Revenue Highlights

Latest Revenue (Y)

$1.91M

Latest Revenue (Q)

$425.86K

Carmell Therapeutics Revenue by Period

Carmell Therapeutics Revenue by Year

DateRevenueChange
2025-12-31$1.91M3701.44%
2024-12-31$50.32K100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31--

Carmell Therapeutics generated $1.91M in revenue during NA 2025, up 3701.44% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Carmell Therapeutics Revenue by Quarter

DateRevenueChange
2025-09-30$425.86K-15.44%
2025-06-30$503.61K-1.32%
2025-03-31$510.35K2819.81%
2024-12-31$17.48K-14.82%
2024-09-30$20.52K66.55%
2024-06-30$12.32K100.00%
2024-03-31--100.00%
2023-12-31$-3.73M-200.00%
2023-09-30$3.73M100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30--

Carmell Therapeutics generated $425.86K in revenue during Q3 2025, up -15.44% compared to the previous quarter, and up 3456.69% compared to the same period a year ago.

Carmell Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MODVModivCare$2.79B$679.71M
XBIOXenetic Biosciences$2.98M$1.03M
CTCXCarmell Therapeutics$1.91M$425.86K
TECXTectonic Therapeutic--
NEUPNeuphoria Therapeutics--

CTCX Revenue FAQ

What is Carmell Therapeutics’s yearly revenue?

Carmell Therapeutics's yearly revenue for 2025 was $1.91M, representing an increase of 3701.44% compared to 2024. The company's yearly revenue for 2024 was $50.32K, representing an increase of 100.00% compared to 2023. CTCX's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022.

What is Carmell Therapeutics’s quarterly revenue?

Carmell Therapeutics's quarterly revenue for Q3 2025 was $425.86K, a -15.44% decrease from the previous quarter (Q2 2025), and a 1975.46% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $503.61K, a -1.32% decrease from the previous quarter (Q1 2025), and a 3987.76% increase year-over-year (Q2 2024). CTCX's quarterly revenue for Q1 2025 was $510.35K, a 2819.81% increase from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Carmell Therapeutics’s revenue growth rate?

Carmell Therapeutics's revenue growth rate for the last 3 years (2023-2025) was 0%, and for the last 5 years (2021-2025) was 0%.